Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lantern Pharma Awarded Orphan Designation Status For "(+)N-hydroxy-N-(methylacylfulvene)urea" For The Treatment Of Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC And BCL2 Rearrangements

Author: Benzinga Newsdesk | November 28, 2023 10:50am

Posted In: LTRN